Rock Springs Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Rock Springs Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-187,500	Closed	-$4.07M	–	145
2018 Q3	$4.07M	Hold	187,500	–	–	0.15%	125
2018 Q2	$3.31M	Hold	187,500	–	–	0.13%	128
2018 Q1	$3.95M	Hold	187,500	–	–	0.17%	125
2017 Q4	$2.71M	Hold	187,500	–	–	0.12%	127
2017 Q3	$2.96M	Hold	187,500	–	–	0.14%	121
2017 Q2	$2.33M	Sell	187,500 -2,500	-1%	-$29K	0.12%	126
2017 Q1	$3.09M	Hold	190,000	–	–	0.18%	110
2016 Q4	$2.87M	Hold	190,000	–	–	0.19%	100
2016 Q3	$2.9M	Hold	190,000	–	–	0.18%	109
2016 Q2	$7.38M	Buy	190,000 +2,500	+1%	+$89.8K	0.55%	56
2016 Q1	$5.21M	Buy	187,500 +7,500	+4%	+$250K	0.44%	75
2015 Q4	$9.68M	Hold	180,000	–	–	0.73%	46
2015 Q3	$7.21M	Buy	+180,000	New	+$5.87M	0.59%	61

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rock Springs Capital Management's ITCI Position: Q4 2018 in Review

Rock Springs Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2018, closing a stake of 187,500 shares — an estimated $4.07M sold.

Rock Springs Capital Management first reported a position in ITCI in Q3 2015 and held it in 13 quarters. The position peaked at $9.68M in Q4 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q4 2018.

Rock Springs Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2018 after selling out during the quarter.
Rock Springs Capital Management sold 187,500 Intra-Cellular Therapies Inc. shares in Q4 2018, an estimated $4.07M.
Rock Springs Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 13 quarters.
Rock Springs Capital Management's Intra-Cellular Therapies Inc. position peaked at $9.68M in Q4 2015.
127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2018.

Based on Rock Springs Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.